ALX Oncology
ALXO
$14.21
Share price
-3.07%
Change (1 day)
125.20%
Change (1 year)
Categories
Operating Margin for ALX Oncology (ALXO)
Operating Margin as of May 2024 (TTM): -3,849.32%
According to ALX Oncology's latest financial reports and stock price the company's current Operating Margin is -3,849.32%. At the end of 2020 the company had an Operating Margin of -3,849.32%.
Operating Margin history for ALX Oncology from 2019 to 2020
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2020 | -3,849.32% | 861.08% |
| 2019 | -400.52% | -39.51% |
| 2018 | -662.12% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.